ARISTO PHARMA LIMITED

Company number 09225220 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£338,131

Balance sheet as at 2025-12-31

View full accounts →

Overview

Company type
Private Limited Company
Incorporated
2014-09-18
Employees
3 (2025 accounts · was 4 in 2024)
Registered office
The North Suite Avro House, Lancaster Way Business Park, Ely, CB6 3NW
Postcode
CB6 3NW
Capital
10,000 GBP
Accounts category
Small

Accounts

Last made up to
2025-12-31
Next due by
2027-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2026-06-30
Next due by
2027-07-14
View filing history →

Nature of business (SIC)

  • 74909 Other professional, scientific and technical activities not elsewhere classified

Officers 2 current · 5 resigned

Marian KOMAR Director
Appointed 2025-01-01
Appointed 2025-01-01

View all officers and resignations →

Data protection registration

Registered with the ICO as a data protection fee payer — ZA108248 (Tier 1), registered since 2015.

Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.

Contact details

Website
aristo-pharma.co.uk

Aristo Pharma are a leader in generic and branded medicines, which are both high quality and cost-effective for patients. Aristo Pharma.

Previous company names

NameDate changed
CEB PHARMA LIMITED2017-03-01

Among its peers

Top 25%

by shareholders' funds, of 570 similar companies in CB

Among the biggest employers among its local peers (3 staff).

Trading since 2014.

109 companies are registered at this postcode →

Competitors Cambridge

This company ranks 61 among other professional, scientific and technical activities not elsewhere classified in Cambridge.

Full league table →

The class of 2014

30%

of the 8,771 companies in this sector incorporated in 2014 are still active today; 66% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →